Table 1.
Clinical and laboratory features of 135 TPP patients.
| Study | Reference range | Result |
|---|---|---|
| Clinical feature | ||
| Gender (male/female) | NA | 130:5 |
| Age (years) | NA | 30.6±8.2 |
| BMI (kg/m2) | 18.5–24.9 | 25.3±3.6 |
| Systolic blood pressure (mmHg) | NA | 140.0±14.4 |
| Diastolic blood pressure (mmHg) | NA | 76.1±10.4 |
| Heart rate (beats/min) | NA | 98.8±14.5 |
| Plasma | ||
| TSH (μU/ml) | 0.25–5.00 | <0.03 |
| Tri-iodothyronine (ng/dl) | 86.0–187.0 | 244.0±95.1 |
| Free thyroxine (ng/dl) | 0.8–2.0 | 4.5±2.75 |
| Na+ (mmol/l) | 136–145 | 139±3 |
| Initial K+ (mmol/l) | 3.5–5.1 | 2.17±0.4 |
| Cl− (mmol/l) | 98–107 | 106±2 |
| pH | 7.35–7.45 | 7.40±0.02 |
| Bicarbonate (mmol/l) | 22.0–26.0 | 23±2 |
| Ionized calcium (mg/dl) | 4.5–5.3 | 4.81±0.22 |
| Phosphate (mg/dl) | 2.7–4.5 | 2.34±0.77 |
| Creatinine (mg/dl) | 0.7–1.2 | 0.60±0.15 |
| eGFR (ml/min per 1.73 m2) | 90–120 | 168.1±37.8 |